News Focus
News Focus
icon url

Millstone

09/08/20 9:52 PM

#19545 RE: MD2Trader #19538

Bravo MD2Trader. I appreciate your post. You obviously have a trader's perspective and a scientific/medical perspective. You see that Aviptadil is the real deal, and have committed to see the investment to its fruition. Tell me, did it surprise you as well that 19 of 21 consecutive critical Covid-19 cases were successfully treated? Patients that were so dire they couldn't even get into the critical trial. Excluded based on their horrible condition. Yet, the compassionate use extension took all comers, without picking and choosing, and healed them one after another.

Consecutive. It still amazes me.

This therapeutic, RLF-100/Aviptadil/SamiVir, is the key to ending deaths from Covid-19. For starters.

icon url

trademax42

09/08/20 10:05 PM

#19547 RE: MD2Trader #19538

Nice to have you on board MD2Trader. Its refreshing to hear from someone who knows the medical aspect of the stock.

Keep your post coming.

$RLFTF

Imho only.
icon url

nelskof

09/09/20 12:52 AM

#19572 RE: MD2Trader #19538

I'm with you doc. I never go heavy in a penny stock but this is a completely different set of circumstances unlike anything we've seen in the modern medical or investing world. I'm an options trader with the risk-on portion of my portfolio and growth equities for long term. If we see the 40's I'm definitely averaging down as low as it goes. Current positions at 50-53c across 3 different accounts.

Hopefully my UCO and QQQ calls start hitting tomorrow and I'll throw profits in here and HGEN.

Are you all in RLFTF or looking at any other complimentary plays?

I prefer the quietness from Dr Javitt and team. To me, it means they're working.

icon url

ratna1

09/09/20 2:52 AM

#19579 RE: MD2Trader #19538

omnia praeclara rara